Andrew Ashe
2022
In 2022, Andrew Ashe earned a total compensation of $3.3M as President, Chief Operating Officer and General Counsel at Verve Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $215,280 |
---|---|
Option Awards | $2,615,650 |
Salary | $476,100 |
Other | $12,468 |
Total | $3,319,498 |
Ashe received $2.6M in option awards, accounting for 79% of the total pay in 2022.
Ashe also received $215.3K in non-equity incentive plan, $476.1K in salary and $12.5K in other compensation.
Rankings
In 2022, Andrew Ashe's compensation ranked 1,088th out of 5,753 executives tracked by ExecPay. In other words, Ashe earned more than 81.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,088 | 81st |
Manufacturing | 518 | 84th |
Chemicals And Allied Products | 187 | 87th |
Drugs | 168 | 87th |
Pharmaceutical Preparations | 126 | 87th |
Ashe's colleagues
We found two more compensation records of executives who worked with Andrew Ashe at Verve Therapeutics in 2022.